
Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU
Author(s) -
Nursel Çalık Başaran,
Oğuz Abdullah Uyaroğlu,
Gülçin Telli Dizman,
Lale Özışık,
Taha Koray Şahin,
Zahit Taş,
Ahmet Çağkan İnkaya,
Sevilay Karahan,
Şehnaz Alp,
Alpaslan Alp,
Gökhan Metan,
Pınar Zarakol,
Gülay Sain Güven,
Şerife Gül Öz,
Arzu Topeli,
Ömrüm Uzun,
Murat Akova,
Serhat Ünal
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2006-173
Subject(s) - medicine , hydroxychloroquine , azithromycin , pneumonia , covid-19 , observational study , pediatrics , radiological weapon , pandemic , university hospital , disease , surgery , infectious disease (medical specialty) , antibiotics , microbiology and biotechnology , biology
Despite the fact that the COVID-19 pandemic has been going on for over 5 months, there is yet to be a standard management policy for all patients including those with mild-to-moderate cases. We evaluated the role of early hospitalization in combination with early antiviral therapy with COVID-19 patients in a tertiary care university hospital.